Sunrise Realty Trust, Inc. (SUNS)
NASDAQ: SUNS · Real-Time Price · USD
14.95
-0.34 (-2.22%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

Sunrise Realty Trust, Inc. engages in commercial real estate (CRE) lending business.

It focuses on originating CRE debt investments and providing capital to borrowers and sponsors with transitional business plans collateralized by CRE assets.

The company intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes.

Sunrise Realty Trust, Inc. was incorporated in 2023 and is based in West Palm Beach, Florida.

Sunrise Realty Trust, Inc.
Country United States
Founded 2023
Industry REIT - Mortgage
Sector Real Estate
CEO Brian Sedrish

Contact Details

Address:
525 Okeechobee Blvd., Suite 1650
West Palm Beach, Florida 33401
United States
Phone 561-510-2390
Website sunriserealtytrust.com

Stock Details

Ticker Symbol SUNS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002012706
CUSIP Number 867981102
ISIN Number US8679811021
SIC Code 6798

Key Executives

Name Position
Brian Sedrish Chief Executive Officer and Director
Robyn Tannenbaum President
Brandon Hetzel Chief Financial Officer and Treasurer
Gabriel A. Katz Chief Legal Officer
James F. Velgot Chief Marketing Officer
Stuart Swann Managing Director
Christopher Gioia Managing Director

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 8-K Current Report
Nov 7, 2024 10-Q Quarterly Report
Oct 22, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 26, 2024 8-K Current Report
Aug 14, 2024 8-K Current Report
Aug 14, 2024 10-Q Quarterly Report
Jul 12, 2024 S-8 Securities to be offered to employees in employee benefit plans
Jul 9, 2024 8-K Current Report